#FRCV

Prenatal exposure to antibiotics and risk of childhood overweight or obesity: a systematic review and meta-analysis

Solans M, Barceló MA, Morales-Suárez M, Moya A, Saez M. Obesity Reviews 2022; 23(S1):e13382. doi: 10.1111/obr.13382 (Impact Factor: 8.900, ENDOCRINOLOGY & METHABOLISM, 11/145 Q1).

Clinical epidemiology FRCV Method:Systematic review and meta-analysis Q1
Read more
The role first-day readings play in a three-day schedule of self-monitoring home blood pressure based on prognostic data. Vampahica study

Bayó J, Dalfó A, Barceló MA, Saez M, Roca C, Pallozzi J, Coll-de-Tuero G. American Journal of Hypertension 2020; 33(2): 156-160. doi: 10.1093/ajh/hpz178 (Impact Factor: 2.689, PERIPHERAL VASCULAR DISEASE, 41/65 Q3)

Clinical epidemiology FRCV GLMM model Method:Generalized models Q3 Selection on unobservables:Mixed models White coat
Read more
Coste de la hipertensión arterial en España

Saez M, Barceló MA. Hipertensión y Riesgo Vascular 2012; 29(4):145-151. doi: 10.1016/j.hipert.2012.07.003

Download
Clinical epidemiology FRCV Method:Evaluation of diagnostic tests Method:Systematic review and meta-analysis non JCR
What is the optimal cut-off threshold when self-monitoring blood pressure at home?

Coll-de-Tuero G, Saez M, Rodríguez-Poncelas A, Bayó-Llibre J, Beltrán-Vilella M, Reyes-Negre C, Dalfó-Baqué A, Barceló MA. Medicine 2019; 98(1):e14817. doi: 10.1097/MD.0000000000014817 (Impact Factor: 1.870, MEDICINE, GENERAL & INTERNAL, 69/160 Q2)

Download
Clinical epidemiology FRCV GLMM model Method:Generalized models Q2 Selection on unobservables:Mixed models White coat
Read more
Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse?

Coll-de-Tuero G, Sanmartín M, Vargas S, Trèmols S, Saez M, Barceló MA. Blood Pressure 2004; 13:164-168. doi: 10.1080/08037050410033286 (Impact Factor: 2.292, PERIPHERAL VASCULAR DISEASE 38/65 Q3)

Clinical epidemiology FRCV GLM model Method:Generalized models Q3 Selection on observables:Regression models White coat
Valoración de la automedida de la presión arterial en el diagnóstico de la hipertensión clínica aislada. Estudio VAMPAHICA

Coll-de-Tuero G, Foguet Q, Rodríguez-Poncelas A, Sanmartín M, Saez M, Barceló MA, VAMPAHICA Study Group. Atención Primaria 2006; 37(6):355-359. doi: 10.1157/13086703 (Impact Factor: 1.346, MEDICINE, GENERAL & INTERNAL 88/160 Q3)

Download
Clinical epidemiology FRCV Method:Protocol Q3 White coat
Assessment of self-monitoring of blood pressure in the diagnosis of isolated clinic hypertension

Coll-de-Tuero G, Foguet Q, Rodríguez-Poncelas A, Salleras N, Saez M, Barceló MA, VAMPAHICA Study Group. Blood Pressure 2006; 15(4):227-236. doi: 10.1080/08037050600912203 (Impact Factor: 2.292, PERIPHERAL VASCULAR DISEASE 38/65 Q3)

Download
Clinical epidemiology FRCV GLM model Method:Generalized models Q3 Selection on observables:Regression models White coat
Proportion of isolated clinical hypertension in primary care settings. Comparison of target organ damage in patients with isolated clinical hypertension and patients with sustained arterial hypertension

Foguet-Borau Q, Coll-de-Tuero G, Rodríguez-Poncelas A, Sanmartín-Albertos M, Saez M, Barceló MA, Pena-Seijo M, Pose-Reino A. Blood Pressure 2007; 16:354-361. doi: 10.1080/08037050701538089 (Impact Factor: 2.292, PERIPHERAL VASCULAR DISEASE 38/65 Q3)

Download
Clinical epidemiology FRCV GLM model Method:Generalized models Q3 Selection on observables:Regression models White coat
Valores de normalidad de la automedida de la presión arterial en relación a la presencia de lesión en los órganos diana. Datos del estudio VAMPAHICA

Coll-de-Tuero G, Foguet-Boreu Q, Rodríguez-Poncelas A, Creus-Bosch R, Sanmartín-Albertos M, Saez M, Barceló MA, Salleras-Marcó N. Medicina Clínica 2008; 130(9):321-326. doi: 10.1157/13117348 (Impact Factor: 1.277, MEDICINE, GENERAL & INTERNAL 91/160 Q3)

Download
Clinical epidemiology FRCV GLM model Method:Generalized models Q3 Selection on observables:Regression models White coat
Individual socioeconomic factors conditioning cardiovascular disease risk

Barceló MA, Saez M, Coll-de-Tuero G. American Journal of Hypertension 2009; 22(10):1085-1095. doi: 10.1038/ajh.2009.146 (Impact Factor: 2.530, PERIPHERAL VASCULAR DISEASE 33/65 Q3)

Download
Clinical epidemiology FRCV GLM model Metabolic syndrome and its components Method:Generalized models Q3 Selection on observables:Regression models